Bard Associates’s Aehr Test Systems AEHR Stock Holding History

Bard Associates’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.1M	Sell	156,900 -22,227	-12%	-$2.03M	3.35%	6
2026 Q1	$6.64M	Sell	179,127 -666	-0.4%	-$21.3K	1.67%	14
2025 Q4	$3.63M	Sell	179,793 -1,827	-1%	-$44.2K	0.93%	38
2025 Q3	$5.47M	Sell	181,620 -12,920	-7%	-$280K	1.45%	21
2025 Q2	$2.52M	Buy	+194,540	New	+$1.85M	0.81%	42

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bard Associates's AEHR Position: Q2 2026 in Review

Bard Associates reduced its Aehr Test Systems (AEHR) stake by 12% in Q2 2026, selling an estimated $2.03M and leaving 156,900 shares worth $15.1M. The position accounts for 3.35% of the portfolio, ranked #6.

Bard Associates first reported a position in AEHR in Q2 2025 and has held it in 5 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Bard Associates held 156,900 shares of Aehr Test Systems worth $15.1M as of Q2 2026.
Bard Associates sold 22,227 Aehr Test Systems shares in Q2 2026, an estimated $2.03M.
Aehr Test Systems made up 3.35% of Bard Associates's portfolio in Q2 2026, its #6 holding.
Bard Associates first reported a position in Aehr Test Systems in Q2 2025 and has held it in 5 quarters since.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.